Lvm-MD-14 (Prea/Pmr/Phase 3/Double-Blind)
Research payments
$42,120
Through program year 2021, $42,120 in research payments was reported against Lvm-MD-14 (Prea/Pmr/Phase 3/Double-Blind), across 38 payments, paid by Allergan Inc..
- Paid by
- Allergan Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $42,120 | 38 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Bernardo Ng Imperial, CA Named on 1 payment
- Robert Riesenberg Atlanta, GA Named on 1 payment
- David Purselle Atlanta, GA Named on 1 payment
- Sejal Mehta Plano, TX Named on 1 payment
- Robert Molpus Longwood, FL Named on 1 payment
- Sherry Soefje Oceanside, CA Named on 1 payment
- Elizabeth Zarate-Rowell Seal Beach, CA Named on 1 payment
- Walter Duffy Lincoln, NE Named on 1 payment
- Lawrence Ginsberg Houston, TX Named on 1 payment
- Alain Katic Bellaire, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.